Company intelligence / Profile preview

Adjupharm

Bad Oldesloe, Schleswig-Holstein, Germany

Ownership: Private
Development stage: Other

Overview

Adjupharm is a leading pharmaceutical distributor specializing in EU-GMP certified medical cannabis, serving over 6,000 pharmacies in Germany, and is reported to be the sixth-largest distributor of medical cannabis flowers in the country, with significant growth and a strong logistics platform.

Therapeutic areas: OncologyNeurologyOther
Modalities: Small moleculeBiologic
Industry: Consulting

Partnerships

Avant Brands (BLK MKT brand licensing)Northern Green Canada (EU-GMP supply agreement)MediPharm Labs (supply agreement)

Beyond the preview

Go deeper on Adjupharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adjupharm.

Explore the full profile